Form4insider filings, from the source

SEC Form 4 · accession 0000899243-17-000042

REATA PHARMACEUTICALS INC · RETA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
William Rose
Director · 10% Owner · Other
Charles E. Gale
10% Owner · Other
Period of report
Dec 29, 2016
Accepted (ET)
Jan 3, 2017 · 1:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358762

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A Common StockF4Dec 29, 2016J145,454$0.00D811,546IBy Puffin
Class A Common StockF5Dec 29, 2016J37,909$0.00A180,909IBy Montrose
Class A Common StockF6Dec 29, 2016J12,091$0.00A13,517D
Class A Common StockF7Dec 29, 2016G100,985$0.00D67,735ISee footnote
Class A Common StockF8holding———11,618D
Class A Common StockF9holding———7,886D
Class A Common StockF10holding———29D
Class A Common StockF11holding———20IBy trust
Class A Common StockF12holding———45IBy trust

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

The reporting persons may be deemed to be members of a group with other affiliated entities that collectively are 10% owners, which group includes William E. Rose, the Estate of Edward W. Rose III, Evelyn P. Rose, Evelyn P. Rose Fidelity Rollover IRA, Charles Henry Rose 2001 Trust, John William Rose 2002 Trust, Charles E. Gale, Charles E. Gale Fidelity Rollover IRA, Puffin Partners, L.P., Puffin GP, LLC, Montrose Investments I, L.P. and Montrose Investments GP, LLC (collectively, the "Affiliated Rose Reporting Persons"). The reporting persons disclaim the existence of a group and disclaim beneficial ownership of any securities held by the other Affiliated Rose Reporting Persons, except to the extent of their respective pecuniary interests therein.